You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serotypes

Showing 1 - 25 of 621
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemophilia A Trial (Biospecimen Collection)

Not yet recruiting
  • Hemophilia A
  • Biospecimen Collection
  • (no location specified)
Oct 11, 2022

Prevention of Dengue Fever Trial in Adelaide (Dengusiil, Placebo)

Completed
  • Prevention of Dengue Fever
  • Dengusiil
  • Placebo
  • Adelaide, South Australia, Australia
    CMAX Clinical Research Pty Ltd
Aug 16, 2022

Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in United States (Live, attenuated, recombinant dengue serotypes 1, 2, 3,

Completed
Has Results
  • Dengue
  • +3 more
  • Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
  • Yellow Fever
  • Alabaster, Alabama
  • +6 more
Mar 15, 2022

Seroprevalence and Seroconversion of Antibodies to

Recruiting
  • Hemophilia A
  • Blood sample collection
  • Madison, Wisconsin
    Covance Inc
Sep 16, 2022

Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Chulucanas Morropon (CYD Dengue Vaccine Serotypes 1, 2, 3, and 4,

Completed
Has Results
  • Dengue Virus
  • +3 more
  • CYD Dengue Vaccine Serotypes 1, 2, 3, and 4
  • Pneumococcal polysaccharide vaccine
  • Chulucanas Morropon, Piura, Peru
    (unnamed)
Mar 10, 2022

Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Long Xuyên (CYD dengue vaccine serotypes (1, 2, 3, 4).,

Completed
Has Results
  • Dengue Virus
  • +3 more
  • CYD dengue vaccine serotypes (1, 2, 3, 4).
  • Meningococcal Polysaccharide A+C; NaCl; Typhoid Vi polysaccharide
  • Long Xuyên, An Giang Province, Vietnam
    Sanofi Pasteur Investigational Site
Mar 15, 2022

Dengue Fever, Dengue Hemorrhagic Fever Trial in Malaysia (Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus,

Completed
Has Results
  • Dengue Fever
  • Dengue Hemorrhagic Fever
  • Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
  • Placebo: NaCl 0.9%
  • Ipoh, Perak, Malaysia
  • +3 more
Mar 15, 2022

Streptococcus Pneumoniae Serotypes Prevalence UsingUrinary Kit

Not yet recruiting
  • Community-acquired Pneumonia
  • urine test
  • (no location specified)
Nov 23, 2020

Pneumonia, Pneumococcal, Invasive Pneumococcal Disease, Acute Otitis Media Trial in Smolensk (Detection of Streptococcus

Completed
  • Pneumonia, Pneumococcal
  • +2 more
  • Detection of Streptococcus pneumoniae strains
  • Smolensk, Russian Federation
    The Interregional Association for Clinical Microbiology and Anti
Feb 8, 2021

Diarrhoea Trial in Gent (drug, biological, combination product)

Recruiting
  • Diarrhoea
  • altSonflex Placebo
  • +8 more
  • Gent, Belgium
    GSK Investigational Site
Apr 18, 2022

Diseases Caused by Streptococcus Pneumoniae Serotypes Trial (7-valent pneumococcal conjugate vaccine, 13-valent pneumococcal

Completed
  • Diseases Caused by Streptococcus Pneumoniae Serotypes
  • 7-valent pneumococcal conjugate vaccine
  • 13-valent pneumococcal polysaccharide conjugate vaccine
  • (no location specified)
Oct 11, 2020

Pneumococcal Disease Trial in Chile, United States (V116, Placebo, PCV15)

Active, not recruiting
  • Pneumococcal Disease
  • V116
  • +3 more
  • Phoenix, Arizona
  • +19 more
Dec 21, 2022

Healthy Trial in Phoenix (Botulinum Antitoxin Heptavalent (A B C D E F G) - (EQUINE))

Completed
  • Healthy
  • Botulinum Antitoxin Heptavalent (A B C D E F G) - (EQUINE)
  • Phoenix, Arizona
    MDS Pharma Services
Mar 3, 2020

Lebanese Interhospital Pneumococcal Surveillance Program

Recruiting
  • Pneumonia
  • +3 more
    • Beirut, Lebanon
      American University of Beirut
    Feb 2, 2023

    Pneumococcal Disease Trial in Japan (V116, PPSV23)

    Recruiting
    • Pneumococcal Disease
    • V116
    • PPSV23
    • Osaka-shi, Osaka, Japan
    • +7 more
    Jan 18, 2023

    20-Valent Pneumococcal Conjugate Vaccine Against Vaccine-Type

    Not yet recruiting
    • Pneumonia
      • (no location specified)
      Jul 6, 2022

      Pneumococcal Disease Trial in United States (V116, PPSV23)

      Not yet recruiting
      • Pneumococcal Disease
      • V116
      • PPSV23
      • (no location specified)
      Jul 12, 2022

      Pneumococcal Disease Trial in Worldwide (V116, PPSV23)

      Recruiting
      • Pneumococcal Disease
      • V116
      • PPSV23
      • Blacktown, New South Wales, Australia
      • +50 more
      Jan 25, 2023

      Hospitalized Pneumococcal Community Acquired Pneumonia in France

      Recruiting
      • Pneumonia
      • +2 more
        • Rennes, Bretagne, France
          CHU Rennes
        May 12, 2022

        Pneumococcal Vaccines Trial (12-Valent Pneumococcal Conjugate Vaccine)

        Not yet recruiting
        • Pneumococcal Vaccines
        • 12-Valent Pneumococcal Conjugate Vaccine
        • (no location specified)
        Jan 31, 2023

        Dengue Trial (V181, Butantan-DV)

        Not yet recruiting
        • Dengue
        • V181
        • Butantan-DV
        • (no location specified)
        Jan 24, 2023

        Pneumococcal Infections Trial in Jena (PCV13, PPV23)

        Active, not recruiting
        • Pneumococcal Infections
        • Jena, Germany
          Center of Infectious Diseases and Infection Control, Jena Univer
        Nov 9, 2022

        Dengue Fever, Dengue Hemorrhagic Fever Trial in Australia (Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virus,

        Completed
        Has Results
        • Dengue Fever
        • Dengue Hemorrhagic Fever
        • Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virus
        • Placebo: NaCl 0.9%
        • Adelaide, Australia
        • +7 more
        May 21, 2019

        Pneumococcal Disease Trial in Worldwide (V116, PCV20)

        Recruiting
        • Pneumococcal Disease
        • V116
        • PCV20
        • Birmingham, Alabama
        • +67 more
        Aug 17, 2022

        Group B Streptococcus (GBS) Disease Trial in Via Mastri, 36 (Group B streptococcus (GBS) vaccine)

        Completed
        • Group B Streptococcus (GBS) Disease
        • Group B streptococcus (GBS) vaccine
        • Via Mastri, 36, CH - 6853 Ligornetto, Switzerland
          Institute for Pharmacokinetic and Analytical Studies
        Feb 8, 2020